Mar 26, 2026Pharmacotherapy

SGLT2 vs GLP-1 Heart Protection Changes With Age

A large diabetes meta-analysis finds age may shift the relative heart benefit of SGLT2 inhibitors and GLP-1 drugs, while sex does not.

ozempicglp-1 agonistssglt2 inhibitorscardiovascular outcomes

Read article →

Mar 21, 2026Neuroprotection

Do GLP-1 Drugs Lower Seizure Risk? An Early Signal

GLP-1 receptor agonists showed fewer seizure events in diabetes trials, but sparse data, stroke effects, and weak endpoints limit conclusions.

glp-1ozempicvictozaseizure risk

Read article →

Mar 21, 2026Mental Health

GLP-1 Drugs and Vascular Dementia: A Signal, Not Proof

GLP-1 receptor agonists may reduce vascular dementia risk, but randomized evidence remains imprecise. What the stroke data and cohorts actually show.

glp-1semaglutidevascular dementiaozempic

Read article →

Mar 21, 2026Medication Safety

Do GLP-1 Drugs Raise Suicide Risk? What Trials Show

FDA and EMA reviews raised alarm about GLP-1 drugs and suicide. Placebo-controlled trials find no increased risk, but key gaps remain.

glp-1 agonistssemaglutidesuicidal ideationozempic

Read article →

Mar 21, 2026Diabetes Medications

Ozempic and Eye Risk: When Rapid A1c Drops Can Backfire

Can Ozempic worsen diabetic retinopathy? Evidence points to rapid A1c drops in people with existing disease, not a class-wide retinal toxin.

ozempicsemaglutidediabetic retinopathyglp-1 agonists

Read article →

Mar 10, 2026Sarcopenia

Do GLP-1 Drugs Cause Muscle Loss? What Human Data Show

Do Ozempic and other GLP-1 drugs cause muscle loss? Review the uncertain human evidence, the concern for older adults with type 2 diabetes, and practical safeguards.

glp-1 agonistsozempicwegovylean mass loss

Read article →

Mar 1, 2026Drug Safety

GLP-1 Drugs and Sudden Vision Loss: What the NAION Data Show

A large meta-analysis links GLP-1 drugs to NAION, a rare cause of sudden vision loss. The signal is small, observational, and not confirmed in trials.

glp-1 agonistsozempicsemaglutideoptic neuropathy

Read article →

Feb 24, 2026Longevity Research

GLP-1 Drugs as Longevity Tools: What the Science Actually Shows

GLP-1 drugs have solid heart benefits — the rejuvenation narrative is built on mouse studies and editorial hype. Here's what the evidence actually shows.

glp-1ozempicautophagycardioprotection

Read article →